Prevalence of the Victimization and the Perpetration of Intimate Partner Violence Among the Patients From Puy-de-Dôme and Paris Consulting or Being Hospitalized for Addiction Problems and Their Expectations From General Practitioners (VIA-MG)

NCT ID: NCT05163171

Last Updated: 2022-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

122 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-10

Study Completion Date

2022-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intimate partner violence and addictions are two frequent problematics with many consequences on health. A link between intimate partner violence and addictions has been found in many studies. Being a drug user increases the risk to be a perpetrator and also a victim of intimate partner violence.

So, it is legitimate to question ourselves about the prevalence of the victims and perpetrators of intimate partner violence among the patients consulting or being hospitalized for an addiction problem. We believe that this prevalence will be high among these patients.

On the other hand, the general practitioners are in first line receiving victims and perpetrators of violence and patients with addiction problems. So it is important to know the profiles of these patients and their expectations from their general practitioners.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The different places where the study will take place are:

* 7 outpatient addiction centers: Addictology consultations in CHU Clermont-Ferrand, CH Sainte-Marie, CH Thiers, CH Ambert, ANPAA (Association Nationale de Prévention en Alcoologie et en Addictologie) of Clermont-Ferrand, Thiers and Ambert.
* 3 hospital addiction centers: Addictology hospital services of CHU of Clermont-Ferrand, CH Thiers and Clémentel.

This study will be based on the filling of self-answered questionnaires by the patients consulting or being hospitalized in the different recruited centers. The questionnaire will be proposed to the patient after the consultation with the practitioner. An information about the study and the anonymity will be given to the patient. The filled questionnaire will be put by the patient in a closed envelope and then in a collection box located in the waiting room.

The different boxes of the different centers will be checked regularly and then the questionnaires will be analysed. The analysis of these questionnaires will allow to describe the population consulting or being hospitalized for addiction problems in the Puy-de-Dôme: age, gender, type of the addiction, the presence of intimate partner violence, associated factors of the violence, recourse characteristics to general practitioners and expectations of GP. We will evaluate the prevalence of victimization and perpetration of intimate partner violence among patients consulting or being hospitalized for addiction problems in the Puy-de-Dôme.

We estimate the duration of the study at around 6 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Addiction Violence, Domestic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patient consulting or hospitalized in addiction structure

patient consulting or hospitalized in addiction structure

questionnaire

Intervention Type OTHER

questionnaire for conjugal violence prevalence

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire

questionnaire for conjugal violence prevalence

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 18, being or having been in a relationship, consulting or being hospitalized for an addiction problem
* Patient speaking and writing French
* Patient capable of giving his informed consent to take part to the study
* Affiliation to the social security
* Patient who doesn't have a tobacco addiction only

Exclusion Criteria

* refuse to participate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

General medicine department of Clermont-Ferrand's university

UNKNOWN

Sponsor Role collaborator

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mathilde VICARD-OLAGNE

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Clermont-Ferrand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Clermont-Ferrand

Clermont-Ferrand, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A01356-35

Identifier Type: OTHER

Identifier Source: secondary_id

RNI 2021 VICARD-OLAGNE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.